An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting.
The therapy involves genetically programming cells from the patient’s own immune system to fight the disease.
The research included 30 patients: five adults ages 26 to 60, and 25 children and young adults ages 5 to 22. All were severely ill, with acute lymphoblastic leukemia, and had relapsed several times or had never responded to typical therapies. In more than half, the disease had come back even after a stem-cell transplant, which usually gives patients the best hope of surviving. Their life expectancy was a few months, or in some cases just weeks.
Six months after being treated, 23 of the 30 patients were still alive, and 19 of them have remained in complete remission.
“We have a number of patients who are a year or more out and are in remission and not requiring other therapies,” said Dr. Stephan A. Grupp, who led the part of the study done at Children’s Hospital of Philadelphia. He said those long remissions gave the researchers hope that the treatment would have lasting effects.
Earlier reports by the same researchers involved only a handful of patients, some with chronic rather than acute leukemia. The scientists say the growing number of patients treated helps demonstrate that the findings are real.
The Latest on: Leukemia
via Google News
The Latest on: Leukemia
- Family facing 2nd leukemia battle gets backyard Bowser castleon April 30, 2021 at 11:08 am
Already an unimaginable challenge for any family — having a child with leukemia — has been doubled for the Morrisons: not just one child diagnosed with leukemia, but two.
- Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6on April 30, 2021 at 9:45 am
The application of tyrosine kinase inhibitors (TKIs) in clinic has revolutionized chronic myelogenous leukemia (CML) treatment, but fails to eliminate leukemia stem cells (LSCs), which are considered ...
- Naugatuck Family Battles Leukemia For 2nd Time: Reporton April 30, 2021 at 7:11 am
The Brice family's two young daughters contracted the disease; one overcame it, the other is in the midst of the fight.
- A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemiaon April 30, 2021 at 3:21 am
Several genomic features have been found for acute myeloid leukaemia (AML) but targeted clinical genetic testing fails to predict prognosis. Here, the authors generate an AML prognostic score from RNA ...
- What to Know About Telehealth for Leukemiaon April 29, 2021 at 9:42 am
Telehealth services allow for the delivery of healthcare solutions through technology, improving care for people with leukemia.
- Avocado discovery may point to leukemia treatmenton April 29, 2021 at 9:40 am
A compound in avocados may ultimately offer a route to better leukemia treatment, says a new University of Guelph study.
- Acute myeloid leukemia and fungal infectionson April 28, 2021 at 6:00 pm
People with a diagnosis of acute myeloid leukemia (AML) may have a higher risk of developing infections from fungi such as Candida and Aspergillus. Learn more here.
- What to know about acute myeloid leukemia in childrenon April 28, 2021 at 6:00 pm
Acute myeloid leukemia can cause a fever, fatigue, shortness of breath, and easy bruising or bleeding. Learn more about this type of cancer in children.
- ‘The Challenge’ star Ashley Cain’s infant daughter dies of leukemiaon April 26, 2021 at 7:35 am
According to a heartbreaking Instagram post, Azaylia Diamond Cain, the infant daughter of The Challenge star Ashley Cain, has died after an intense battle with leukemia at just eight months old. Cain ...
- Ashley Cain's 8-month-old daughter, Azaylia, dies after battle with leukemiaon April 26, 2021 at 3:57 am
The former pro soccer player and "The Challenge" star revealed his daughter's cancer diagnosis in October 2020.
via Bing News